跳转至内容
Merck
CN

OP79

Sigma-Aldrich

Anti-p21WAF1 (Ab-6) Mouse mAb (22)

liquid, clone 22, Calbiochem®

别名:

Anti-CIP1, Anti-SD11, Anti-p21, Anti-WAF

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
12352203
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

生物来源

mouse

抗体产品类型

primary antibodies

克隆

22, monoclonal

表单

liquid

包含

≤0.1% sodium azide as preservative

种属反应性

mouse, human, rat

制造商/商品名称

Calbiochem®

储存条件

do not freeze

同位素/亚型

IgG1

运输

wet ice

储存温度

2-8°C

一般描述

This product has been discontinued.



Recognizes the ~21 kDa p21WAF1 protein in rat and mouse embryo fibroblast cell lines treated with actinomycin D.

Purified mouse monoclonal antibody, generated by immunizing BALB/c x C57B1/6 F1 mice with the specified immunogen and fusing splenocytes with myeloma cells. Recognizes the ~21 kDa p21WAF1 protein.

免疫原

Epitope: within amino acids 20-40 of human p21WAF1
recombinant, mouse p21WAF1

应用

Frozen Sections (not recommended)

Immunoblotting (3 µg/ml)

Immunoprecipitation (1 µg/ml)

Paraffin Sections (not recommended)

包装

Please refer to vial label for lot-specific concentration.

分析说明

Positive Control
Induced rat or mouse embryo fibroblasts

其他说明

Agarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA92, 8493.
Chen, Y.Q., et al. 1995. Int. J. Oncology7, 889.
Deng, C., et al. 1995. Cell82, 675.
El-Deiry, W.S., et al. 1995. Cancer Res.55, 2910.
Waldman, T., et al. 1995. Cancer Res.55, 5187.
Elbendary, A., et al. 1994. Cell Growth Diff.5, 1301.
El-Deiry, W.S., et al. 1994. Cancer Res.54, 1169.
Li, R., et al. 1994. Nature371, 534.
Michieli, P., et al. 1994. Cancer Res.54, 3391.
Noda, A., et al. 1994. Exp. Cell Res.211, 90.
El-Deiry, W.S., et al. 1993. Cell75, 817.
Gu, Y., et al. 1993. Nature366, 707.
Harper, J.W., et al. 1993. Cell75, 805.
Xiong, Y., et al. 1993. Nature366, 701.
Xiong, Y., et al. 1993. Genes Devel.7,1572.
Xiong, Y., et al. 1992. Cell71, 505.
Maximal p21WAF1 expression requires wild type p53 activity. Treatment of mouse or rat embryo fibroblasts with DNA damaging agents such as actinomycin D induces wild type p53 expression which in turn activates WAF1 expression. Serum stimulation of quiescent cells will give low level WAF1 expression independent of p53 expression. For immunoblotting applications, antigen/antibody complexes are best visualized using chemiluminescence detection methods. Antibody should be titrated for optimal results in individual systems.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Toxicity: Standard Handling (A)

未找到合适的产品?  

试试我们的产品选型工具.

储存分类代码

10-13 - German Storage Class 10 to 13

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

K E King et al.
Carcinogenesis, 27(1), 53-63 (2005-08-06)
p63 is critical for squamous development and exists as multiple isotypes of two subclasses, TA and DeltaN. DeltaNp63 isotypes can antagonize transcription by TAp63 and p53, and are highly expressed in squamous cell cancers. Using mouse keratinocytes as a biological
Matthew Jennis et al.
Genes & development, 30(8), 918-930 (2016-04-02)
A nonsynonymous single-nucleotide polymorphism at codon 47 in TP53 exists in African-descent populations (P47S, rs1800371; referred to here as S47). Here we report that, in human cell lines and a mouse model, the S47 variant exhibits a modest decrease in
Gregory Azzam et al.
PloS one, 8(9), e74297-e74297 (2013-09-11)
The p53 tumor suppressor gene has a common polymorphism at codon 72 that alters its function. We previously reported that the proline 72 polymorphic variant of p53 (P72) demonstrates increased ability to transactivate a subset of genes, relative to arginine
Che-Pei Kung et al.
Cancer biology & therapy, 18(7), 484-491 (2017-05-06)
The TP53 gene is distinguished as the most frequently mutated gene in cancer. Unlike most cancer-relevant genes, the TP53 gene is also distinguished by the existence of coding region polymorphisms that alter p53 sequence, and in some cases, also alter
Chih-Yen Wang et al.
Frontiers in molecular neuroscience, 11, 4-4 (2018-02-09)
B-cell CLL/lymphoma 11B (Bcl11b) - a C2H2 zinc finger transcriptional factor - is known to regulate neuronal differentiation and function in the development of the central nervous system (CNS). Although its expression is reduced during oligodendrocyte (OLG) differentiation, its biological

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持